Oncology Today with Dr Neil Love
Podcast tekijän mukaan Research To Practice

Kategoriat:
348 Jaksot
-
Renal Cell Carcinoma
Julkaistiin: 4.11.2020 -
Acute Myeloid Leukemia with FLT3 Mutations
Julkaistiin: 30.10.2020 -
Chimeric Antigen Receptor T-Cell Therapy in Non-Hodgkin Lymphoma
Julkaistiin: 27.10.2020 -
PARP Inhibition in the Management of Pancreatic Cancer
Julkaistiin: 23.10.2020 -
Management of Acute Myeloid Leukemia Not Eligible for Intensive Induction Therapy
Julkaistiin: 21.10.2020 -
Front-Line Treatment of Chronic Lymphocytic Leukemia
Julkaistiin: 13.10.2020 -
Hodgkin Lymphoma
Julkaistiin: 2.10.2020 -
Novel Induction and Maintenance Strategies in Acute Myeloid Leukemia Edition
Julkaistiin: 30.9.2020 -
PARP Inhibitors in Breast Cancer Edition
Julkaistiin: 23.9.2020 -
Oncology Today with Dr Neil Love: Myeloproliferative Neoplasms Edition
Julkaistiin: 21.9.2020 -
Oncology Today with Dr Neil Love: EGFR Mutation-Positive Non-Small Cell Lung Cancer Edition
Julkaistiin: 17.9.2020 -
Oncology Today with Dr Neil Love: CAR T-Cell Therapy in Multiple Myeloma Edition
Julkaistiin: 15.9.2020 -
Oncology Today with Dr Neil Love: Immunotherapy for Urothelial Bladder Carcinoma Edition
Julkaistiin: 11.9.2020 -
Oncology Today with Dr Neil Love: Cutaneous Squamous Cell Carcinoma Edition
Julkaistiin: 4.9.2020 -
Oncology Today with Dr Neil Love: Small Cell Lung Cancer Edition
Julkaistiin: 28.8.2020 -
Follicular Lymphoma Roundtable – Drs Carla Casulo and John P Leonard
Julkaistiin: 18.8.2020 -
Oncology Today Special Roundtable: Colorectal Cancer
Julkaistiin: 5.8.2020 -
Dr John Heymach on Angiogenesis Inhibition in Lung Cancer and COVID-19 at MD Anderson
Julkaistiin: 1.8.2020 -
Dr Michael Pishvaian Comments on the Use of PARP Inhibition in the Management of Pancreatic Cancer
Julkaistiin: 17.6.2020 -
Dr Jeff Sharman Comments on the Use of BTK Inhibitors as Treatment for Patients with SARS-CoV-2
Julkaistiin: 5.6.2020
Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.